Altamira Therapeutics Ltd.
Q4 2024 13F Holders
Symbol
CYTOF
CUSIP
G0360L134
Type
Equity
Class
SHS
Num filings
2
Total reported value, excl. options
$1.21 k
Compare 2024 Q4 to
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q3
2024 Q2
2024 Q1
2023 Q4
Manager
Report Date
Value ($000)
Shares
Option Type